Wang et al. profiled the circulating levels of CTLA4 in 182 ccRCC patients and showed that the circulating levels of CTLA4 were correlated with the risk of recurrence in ccRCC patients [19]. Here, CTLA4 is linked to nonpapillary renal cell carcinoma.